Proactive management of the UDI regulatory requirements

To improve patient safety, oversight and post market surveillance, the Food and Drug Administration (FDA) published a Final Rule on Unique Device Identification (UDI) in September 2013. By September 2014, manufacturers of class III medical devices had to adhere and implement the Final Rule, finding that significant time and effort was required to collect, collate and submit all the data that the FDA requires to be uploaded and made publicly available on the Global UDI database (GUDID). Manufacturers of life-supporting or life-sustaining class II products are about to face similar challenges when they strive to meet the UDI rule by September 2015. Other class II products follow in September 2016, with class I products in 2018.

Setting up UDI processes, governance structures and supporting technologies across multiple functions is crucial to successfully manage the information flow throughout the product lifecycle and ensure compliance to the Final Rule. This requires significant effort and poses many challenges for manufacturers: organizations will have to collect information from different stakeholders across functions, define a master data set, validate the data, determine process owners and exchange information with health authorities, strategic partners and production facilities. However, whilst being an initial burden, proactive and skillful manufacturers can also use the new datasets to open up business opportunities: better tracking and tracing of products allows better control of the supply chain and insights into customer needs. Manufacturers should aim to utilize the new regulations for maximum benefit, rather than just complying with the minimum requirements for compliance.

Unique Device Identification (UDI)

Navitas- the leading industry partner for UDI implementation

Expertise in implementing business processes with a focus on safety and supply chain make Navitas an ideal partner to implement UDI solutions.

We have a proven approach to implementation of UDI requirements in which we tailor the following project components to client needs:

  • Conducting a gap analysis between current capabilities and UDI requirements
  • Designing realistic and efficient supporting processes and compliant procedures, including the updating of existing SOPs and work instructions
  • Implementing a tailored governance model, likely to involve multiple stakeholders across many functions
  • Integration of UDI requirements into the overall business strategy
  • Set up of supporting IT infrastructure
  • All
  • AMS
  • BI
  • Brochure
  • CaseStudy
  • Clinical
  • CMS
  • MedicalDevices
  • On DemandWebinar
  • Quality
  • Regulatory
  • Safety
  • Technology
  • Whitepaper

Latest News


ICH Reflection on “GCP Renovation”: Modernization of ICH E8 and...

Navitas welcomes the opportunity to provide comments on this Reflection Paper... Navitas welcomes the opportunity...


Navitas Life Sciences Augments Global Executive Management Team

Navitas Life Sciences announced the appointment of Dr. Krishnan Rajagopalan as Chief Growth Officer....


Navitas Networks announce Forum dates for Spring, 2017

The Navitas Networks are pleased to confirm the dates for our upcoming Spring forums... ...


Navitas Launches Labeling Assessment Express

Regulators are changing the way they look at labeling. The emphasis is on ensuring...


BioVectra chooses pharmaREADY for eCTD Solution

BioVectra has chosen pharmaREADY for its eCTD requirements. BioVectra, located in Canada, manufactures...


Navitas at DIA's 10th Annual Forum for Qualified Persons...

Navitas Principal Jeffrey Ho will present "Efficient content management for the compilation and...


News 2016

[row id="1" class="ROW_CLASS"] [col class="span12"] 02 Nov 2016 AbbVie and Navitas Present Case Study on the Evolution...


Navitas releases paper on CDISC, the standards and why the...

The FDA (and eventually, regulatory agencies from around the world) will require clinical data...


AbbVie and Navitas Present Case Study on the Evolution and...

At 10:30a.m. (East Coast Time) on September 22nd, Navitas and AbbVie will...


Navitas Networks announce Forum dates for Autumn, 2016

The Navitas Networks are pleased to confirm the dates for our upcoming Autumn forums....


Navitas Celebrates 100th pharmaREADY customer

pharmaREADY is Navitas’ intuitive and easy to use, fully integrated, regulatory compliant, web-based suite...


Navitas' PVTech Summit Defines Future Success

Navitas’ PVTech Summit was held on June 15th at the Hudson Hotel in New...


Navitas Welcomes Tara Baer to Navitas

Navitas is pleased to welcome Tara Baer, who joins Navitas' Regulatory Practice. With over...


Navitas Speaks at Sparta Connection in Orlando

David Gwyn, Navitas' Technology Practice lead, will unveil idmpREADY at the Sparta Connection conference...


Navitas Earns Speaking Sessions at DIA’s 52nd Annual Meeting

In two different sessions, Subject Matter Experts from Navitas will address new challenges facing...


Navitas is pleased to announce the introduction of our networks...

Navitas' inaugural pvindia meeting took place in Mumbai on Thursday 03 March, 2016. ...


Navitas Announces the Inaugural pvindia Forum

Navitas will soon be adding to our portfolio of industry leading networks with the...


Navitas Relaunches is Navitas' next generation website for its fully integrated, regulatory compliant document management,...


Steve Arlington, Navitas Advisor, Spoke on the Challenges, Opportunities and...

Steve Arlington, Navitas Advisor, Spoke on the Challenges, Opportunities and Future of the Pharmaceutical...


The changing trends in drivers of life sciences R D...

Outsourcing is not new in the life sciences sector. Clinical research outsourcing, contract sales...